DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - HORIZON PHARMA PLC ownership

HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 227 filers reported holding HORIZON PHARMA PLC in Q3 2015. The put-call ratio across all filers is 0.46 and the average weighting 0.5%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of HORIZON PHARMA PLC
ValueSharesWeighting
Q1 2019$170,807,000
+28.1%
6,462,634
-5.3%
6.55%
+22.7%
Q4 2018$133,375,000
+3.1%
6,825,719
+3.3%
5.34%
+15.2%
Q3 2018$129,422,000
+18.2%
6,609,8940.0%4.64%
+20.6%
Q2 2018$109,460,000
+16.6%
6,609,8940.0%3.84%
+18.2%
Q1 2018$93,860,000
+1.4%
6,609,894
+4.2%
3.25%
-10.8%
Q4 2017$92,592,000
+5.6%
6,341,894
-8.3%
3.64%
-7.8%
Q3 2017$87,708,000
-17.9%
6,917,070
-23.1%
3.95%
-30.6%
Q2 2017$106,811,000
-34.0%
8,998,413
-17.8%
5.70%
-8.7%
Q1 2017$161,767,000
+11.6%
10,944,988
+22.2%
6.24%
+4.6%
Q4 2016$144,924,000
+24.2%
8,956,988
+39.2%
5.96%
+9.9%
Q3 2016$116,656,000
-48.5%
6,434,439
-53.2%
5.43%
-39.0%
Q2 2016$226,302,000
-0.6%
13,740,2610.0%8.89%
-8.3%
Q1 2016$227,676,000
-10.1%
13,740,261
+17.6%
9.69%
-5.5%
Q4 2015$253,210,000
+58.1%
11,684,801
+44.6%
10.26%
+65.6%
Q3 2015$160,173,000
-62.4%
8,081,407
-34.1%
6.20%
-56.3%
Q2 2015$425,908,000
+28.2%
12,259,875
-4.2%
14.19%
+31.9%
Q1 2015$332,226,000
+120.3%
12,792,689
+9.3%
10.76%
+98.6%
Q4 2014$150,801,000
+122.4%
11,699,047
+111.9%
5.42%
+119.3%
Q3 2014$67,793,0005,520,5662.47%
Other shareholders
HORIZON PHARMA PLC shareholders Q3 2015
NameSharesValueWeighting ↓
JABODON PT CO 187,808$4,519,0003.52%
KNOTT DAVID M 50,046$1,204,0000.51%
CASTLEARK MANAGEMENT LLC 362,980$8,733,0000.34%
EAGLE ASSET MANAGEMENT INC 2,692,100$64,771,0000.33%
USA FINANCIAL FORMULAS 15,202$402,0000.20%
Qtron Investments LLC 12,274$295,0000.18%
C WorldWide Group Holding A/S 491,544$11,827,0000.15%
Gotham Asset Management, LLC 207,158$4,984,0000.08%
Russell Investments Group, Ltd. 608,977$14,652,0000.03%
FNY Investment Advisers, LLC 3,350$80,0000.02%
View complete list of HORIZON PHARMA PLC shareholders